Enter your login e-mail to the account
Search
Search parameters
Search results
- Neuroendocrine neoplasia in outpatient clinic of general practitioner
doc. MUDr. Soňa Kiňová, PhD., MUDr. Michal Koreň, PhD.
(3-4/2014, Interdisciplinary consilium ) - Chronic myeloid leukemia – model of successful targeted therapy of oncologic disease
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD
(3-4/2014, Interdisciplinary consilium ) - ROLE OF GENERAL PRACTIONER IN THE TOTAL MANAGEMENT OF LUNG CANCER
doc. MUDr. Peter Beržinec, CSc.
(7-8/2007, Topic ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- New perspectives in cytogenetics and classification of pediatric acute lymphoblastic leukemia
Mgr. Anita Vaská, Mgr. Ágnes Baranyaiová, RNDr. Katarína Skalická, PhD., doc. MUDr. Alexandra Kolenová, PhD.
(2/2017, Review articles )
- Imunoterapie u nádorů ledvin
MUDr. Andrea Ondrušková, doc. MUDr. Hana Študentová, Ph.D.
(3/2023, Review articles ) - Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - The combination of systemic therapy and transarterial chemoembolization in the treatment of symptomatic hepatic metastases of malignant insulinoma
MUDr. Iveta Kopecká, PhD., MUDr. Marián Streško, PhD., MUDr. Abdullah Dammak, MUDr. Viera Skarbová, MUDr. Andrej Klepanec, PhD.
(6/2014, Original articles & case reports ) - Management of pacients with CML resistant or intolerant to tyrosine kinase inhibitor – imatinib
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Juraj Halička, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD.
(4/2012, Topic of the year ) - Treatment of EGFR- mutated non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(1/2021, Main topic ) - Milí čitatelia! - úvodné slovo
prof. MUDr. Stanislav Špánik, CSc.
(1/2011, Editorial ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Biological treatment of the small cell lung cancer
MUDr. Peter Kasan
(1/2007, Review articles ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFRmutant lung cancers
doc. MUDr. Peter Beržinec, CSc.
(6/2013, Information & comments ) - Gastrointestinal stromal tumors and some new treatment options
MUDr. Iveta Andrezálová Vochyanová
(3/2015, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Recommendations for the management of patients with chronic myelocytic leukemia in the Slovak Republic
Kolektív autorov
(S1/2021, Supplement ) - Články publikované v časopise Onkológia v roku 2012 (7. ročník)
(1/2013, online attachment ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Diagnosis of chronic myeloid leukemia
MUDr. Ľudmila Demitrovičová, MUDr. Lucia Copáková, MUDr. Eva Mikušková, Mgr. Michaela Leitnerová
(2/2012, Topic of the year ) - New trends in the treatment of non-small cell renal cell carcinoma
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(4/2022, Main topic ) - Circulating tumor DNA in non-small cell lung cancer patients with epidermal growth factor receptor mutations
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal, prof. MUDr. Eva Rozborilová, CSc.
(5/2020, Review articles ) - Metronomic chemotherapy – promising therapeutical approach for recurrent/ refractory high risk tumours in children
MUDr. Irina Oravkinová, MUDr. Ladislav Deák, MUDr. Jaroslava Feketeová, MUDr. Viktória Halušková, MUDr. Ivana Senčáková, MUDr. Igor Jenčo
(5/2011, Original articles & case reports ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Can we expect „ A new era“ in melanoma?
MUDr. Zuzana Hlavatá
(5/2011, Review articles ) - Myelofibróza – posúdenie nových liečebných možností
MUDr. Antónia Hatalová
(5/2012, Editorial ) - Place of bosutinib in the therapy of chronic myeloid leukemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Angelika Bátorová, PhD.
(3/2016, Drugs & drug classes ) - Treatment of patients with metastatic renal cancer after treatment with tyrosine kinase inhibitors
MUDr. Mária Rečková, PhD.
(4/2019, Review articles ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - 14. svetová konferencia o karcinóme pľúc v Amsterdame
doc. MUDr. Peter Beržinec, CSc.
(5/2011, Events ) - The effectiveness of second-generation ALK-TKIs in advance non-small cell lung cancer
MUDr. Simona Laštíková, MUDr. Michal Urda, PhD., MUDr. Juraj Mazal, MUDr. Marek Lafférs
(6/2021, Case reports ) - Exon 20 insertions and other uncommon EGFR mutations in non-small cell lung cancer
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(4/2023, Review articles ) - The present approach to treatment of renall cell carcinoma
MUDr. Zuzana Syčová-Milá
(5/2010, Review articles ) - Sorafenib and hepatocellular carcinoma
MUDr. Iveta Andrezálová Vochyanová
(1/2014, Drugs & drug classes ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Treatment of metastatic clear cell renal cell carcinoma after failure of first-line treatment
MUDr. Marián Streško, PhD.
(4/2014, Main topic ) - Advances in molecular monitoring and the importance of screening BCR/ABL1 mutation for Ph-positive chronic myelocytic leukemia
MUDr. Adriana Kafková, PhD., prof. MUDr. Elena Tóthová, CSc.
(1/2019, Review articles ) - ELN recommendations for management of CML patients 2013
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD.
(4/2014, Review articles ) - Správa z 15. kongresu Európskej hematologickej spoločnosti v Barcelone
MUDr. Ľudmila Demitrovičová
(5/2010, Events ) - The importance of biological therapy in malignant tumor of unknown primary origin
MUDr. Róbert Godál
(4/2013, Main topic ) - Effectivity of reduced dose of afatinib in patient with metastatic del 19 adenocarcinoma
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal
(3/2020, Case reports ) - VI. Dni mladých onkológov vo Vyhniach
MUDr. Oľga Szegheőová
(5/2010, Events ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - New trends in the treatment of Ph+ acute lymphoblastic leukemia
MUDr. Firas Farkaš, PhD., doc. MUDr. Martin Mistrík, PhD., MUDr. Iveta Simančíková, MUDr. Ladislav Sopko, PhD., MUDr. Katarína Slezáková, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2017, Original articles & case reports ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - XLIII. bratislavských onkologických dní – správa z podujatia
MUDr. Oľga Szegheőová
(4/2006, Events ) - Bioptická diagnostika myeloproliferatívnych neoplázií
MUDr. Juraj Marcinek, PhD., prof. MUDr. Lukáš Plank, CSc.
(2/2018, Spectrum ) - Real life data on ponatinib treatment of chronic myeloid leukemia patients in Slovakia
MUDr. Katarína Slezáková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Iveta Oravcová, PhD., MUDr. Juraj Chudej, PhD., MUDr. Imrich Markuljak, MUDr. Alexander Wild, MUDr. Natália Štecová, prof. MUDr. Elena Tóthová, CSc., MUDr. Eva Mikušková, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2020, Original articles ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - Thyroid cancer
MUDr. Jana Ďurková
(1/2015, Review articles ) - Zaujímavosti zo zahraničnej literatúry
Doc. MUDr. Peter Beržinec, CSc.
(2/2018, Information & comments ) - Zriedkavé nádory gastrointestinálneho systému s akcentom na análny karcinóm
MUDr. Tomáš Šálek
(3/2018, Main topic ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - Chemotherapy of lung cancer – what is new in 2009?
doc. MUDr. Peter Beržinec, CSc.
(1/2010, Review articles ) - Intermediate hepatocellular carcinoma – current treatment options
MUDr. Sylvia Dražilová, PhD., MUDr. Martin Janíčko, PhD.
(4/2015, Review articles ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Biological therapy in colorectal cancer
MUDr. Jozef Dolinský
(2/2011, Review articles ) - Antineoplastic treatment of patients with renal insufficency
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD.
(2/2011, Review articles ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Rare lung cancers
doc. MUDr. Peter Beržinec, CSc.
(2/2013, Main topic ) - Malignant epithelial thymic neoplasms
MUDr. Ján Rajec, PhD., RNDr. Ivan Varga, PhD.
(3/2012, Review articles ) - Chronic myeloid leukemia and its treatment in patients with repeated intolerance of tyrosine kinase inhibitors
MUDr. Radoslav Greksák, PhD.
(2/2020, Case reports ) - Stroke as a consequence of vascular toxicity induced by anticancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., Mgr. Barbora Filová, MUDr. Pavol Janega, PhD.
(5/2013, Review articles ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Správa z IX. bardejovských onkologických dní
doc. MUDr. Mária Wagnerová, CSc.
(4/2016, Events ) - Dual EGFR mutation in patient with non-small cell lung cancer
MUDr. Martin Horný, MUDr. Lucia Doláková, MUDr. Kristína Šuhajdová, MUDr. Klaudia Grácová
(2/2023, Main topic ) - Therapy for chronic myeloid leukemia: Past, present and future
prof. MUDr. Elena Tóthová, CSc.
(1/2012, Topic of the year ) - The role of osimertinib in the treatment of lung cancer
MUDr. Anna Kollárová
(1/2024, Drugs & drug classes ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - VI. Bardejovské onkologické dni
MUDr. Jozef Chovanec
(4/2010, Events ) - Správa z Best of ASCO® Slovakia 2012
MUDr. Mária Rečková
(6/2012, Events ) - New perspectives in cytogenetics and classification of pediatric acute lymphoblastic leukemia
Mgr. Anita Vaská, Mgr. Ágnes Baranyaiová, RNDr. Katarína Skalická, PhD., doc. MUDr. Alexandra Kolenová, PhD.
(1/2017, Review articles ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - 17. svetová konferencia o karcinóme pľúc
Doc. MUDr. Peter Beržinec, CSc.
(1/2017, Events ) - Management of chronic myeloid leukemia after failure of second generation tyrosine kinase inhibitors
MUDr. Katarína Slezáková, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Peter Rohoň, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2022, Review articles ) - Systemic mastocytosis – diagnostics and perspectives of therapy
MUDr. Ján Lazúr
(6/2019, Review articles ) - Zaujímavosti zo zahraničnej literatúry
doc. MUDr. Peter Beržinec, CSc.
(2/2014, Information & comments ) - Úvodné slovo
prof. MUDr. Michal Mego, DrSC.
(1/2018, Editorial ) - Initial treatment of metastatic renal cell carcinoma
MUDr. Jana Obertová, PhD.
(1/2018, Main topic ) - Treatment of relapse and refractory chronic lymphocytic leukemia
MUDr. Natália Štecová
(5/2014, Oncohematology Review ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic ) - Treatment metastatic gastric cancer
MUDr. Vanda Ušáková, PhD.
(1/2018, Review articles ) - News in systemic treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(6/2018, Review articles ) - Niektoré nové poznatky zo sympózia ASCO GI San Francisco 2018
MUDr. Tomáš Šálek
(1/2018, Events ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes ) - ASCO 2008, SPRÁVA Z MEDZINÁRODNÉHO STRETNUTIA ONKOLÓGOV
MUDr. Marcela Tkáčová
(4/2008, Events )
- Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles )